Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine three different ways to control pain after hip replacement:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ropivacaine infiltration and infusion. | Experimental | Ropivicaine infiltration followed by continuous ropivicaine infusion for 48 hours. |
|
| Ropivacaine and Saline | Experimental | Ropivicaine infiltration followed by normal saline infusion. |
|
| Saline infiltration and infusion. | Placebo Comparator | Normal saline infiltration followed by saline infusion. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ropivacaine infiltration and saline infusion. | Procedure | 50ml ropivacaine 0.2% with keterolac 15mg infiltration followed by normal saline infusion at 5ml per hour |
|
| Measure | Description | Time Frame |
|---|---|---|
| The pain medication requirement for 48 hours after surgery in three groups. | 48 hours after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Pain scores, incidence of nausea and vomiting and patient satisfaction in each group. | 48 hours after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sanjay Sinha, M.D. | Saint Francis Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint Francis Hospital and Medical Center | Hartford | Connecticut | 06105 | United States |
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ropivacaine infiltration and infusion. | Procedure | 50 ml infiltration of ropivacaine 0.2% and ketorolac 15mg admixture followed by ropivacaine 0.2 % at 5ml per hour infusion for 48 hours. |
|
| Normal Saline | Procedure | 50ml of normal saline infiltration followed by normal saline infusion at 5ml per hour |
|